-
Ferring and Celmatix launch ambitious genomics collaboration to advance care in reproductive medicine and women’s health
inFerring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering new insights into ovarian…
0 -
New analysis of Rekovelle® data further supports use of AMH to personalise fertility treatment
inFerring Pharmaceuticals announced today a new analysis* of data from the Phase 3 ESTHER-1 trial…
-
Ferring’s heat-stable carbetocin could save thousands of women’s lives by preventing excessive bleeding after childbirth
inFerring Pharmaceuticals today announced new data demonstrating that its heat-stable formulation of carbetocin…
-
Ferring signs global agreement to commercialise novel gene therapy for bladder cancer patients
inFerring Pharmaceuticals today announced the signing of an agreement giving the company the option to secure…
-
Ferring acquires innovative biotechnology company and microbiome pioneer Rebiotix Inc.
inFerring Pharmaceuticals* and Rebiotix Inc. today announce that they have agreed to the acquisition of Rebiotix by Ferring…
-
Nocturia: the most common cause of a poor night’s sleep, say experts on World Sleep Day
inOn World Sleep Day, scientists are highlighting the number one reason that people are waking up at night – nocturia…
-
Ferring announces positive outcome of European Decentralised Procedure (DCP) for Testavan®, a treatment for men with hypogonadism
inFerring Pharmaceuticals today announced the positive outcome of the European Decentralised Procedure (DCP) for Testavan®…
-
March of Dimes and Ferring announce new Prematurity Research Center at Imperial College London
inMarch of Dimes and Ferring Pharmaceuticals today announced that March of Dimes has selected Imperial College London…
-
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage
inFerring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative…
-
Ferring announces 30 million CHF investment in new biotech centre in Switzerland
inFerring Pharmaceuticals announced today that it is expanding its capabilities in biologics through a new biotech centre…
Author archive for pulse
Articles by: pulse